ENTEROPharmacy Retail
Entero Healthcare Solutions — Quarterly Results & Earnings
₹1247.80
+0.05%
Profit Growth YoY33.78%Latest quarter
Sales Growth YoY20.78%Latest quarter
Sales CAGR 5Y30.44%5 year compound
Profit CAGR 5Y151.54%5 year compound
📋
Quarterly Performance
YoY Profit Growth+33.78%
🔥 Exceptional growth
YoY Sales Growth+20.78%
🔥 Exceptional growth
OPM 5Y Average
2.33%Operating profit margin
EPS Growth 5Y
-25.34%Interest Coverage
4.62Higher = safer debt servicing
ROE
5.63%ROCE
8.71%💡
Growth Analysis
Entero Healthcare Solutions reported YoY profit growth of 33.78% and revenue growth of 20.78% in the latest quarter. Double-digit profit growth above 20% is exceptional — indicates strong business momentum. Over 5 years, sales compounded at 30.44% and profits at 151.54% annually. This is above-average growth for Indian listed companies. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.
More on Entero Healthcare Solutions
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.